News of a fresh investigational program was putting some zip into the shares of gene-editing company Prime Medicine (NASDAQ: ...

Shares of Prime Medicine ( PRME 13.07%) are surging on Thursday. The gene-editing company's stock gained 10.5% as of 2 p.m.

The company's technology is impressive, but as a clinical-stage biotech, investing comes with elevated risk. Prime Medicine announced yesterday a new preclinical program for treating alpha-1 ...

Africa Oil's merger boosts cash flow, launches a quarterly dividend, and capitalizes on offshore operations in Nigeria. See ...

Shopify stock is down 21%, presenting a buy-the-dip opportunity. At 68x forward earnings, Shopify's valuation is high. See ...

We recently compiled a list of the 12 Most Widely Held Stocks by Individuals in 2025. In this article, we are going to take a ...

PRIME MEDIA Holdings, Inc. said it had obtained approval from the Securities and Exchange Commission (SEC) for its equity restructuring plan. In a stock exchange disclosure on Thursday, the company ...

Shares in cloud technology company Twilio (TWLO) darkened today despite analysts declaring that it is in a prime position to ...

The SM Group is positioning itself for future growth with continued investments in its core businesses and emerging sectors, ...

The Prime Minister recently spoke to private sector leaders, stressing the shared goal of driving economic growth, boosting investments, supporting s ...

Palantir (NASDAQ:PLTR) rode a massive rally through 2024 and into early 2025, but after hitting an all-time high in ...

ClearBridge Investments, an investment management company, released its “ClearBridge SMid Cap Strategy” fourth quarter 2024 ...